| 1. |
- Baenas, Isabel, et al.
(författare)
-
Impact of COVID-19 Lockdown in Eating Disorders : A Multicentre Collaborative International Study
- 2022
-
Ingår i: Nutrients. - : MDPI AG. - 2072-6643. ; 14:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography. Methods. The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES). Results. Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient. Conclusions. The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients.
|
|
| 2. |
- Fernández-Aranda, Fernando, et al.
(författare)
-
COVID Isolation Eating Scale (CIES) : Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study
- 2020
-
Ingår i: European Eating Disorders Review. - : Wiley. - 1072-4133 .- 1099-0968. ; 28:6, s. 871-883
-
Tidskriftsartikel (refereegranskat)abstract
- Confinement during the COVID-19 pandemic is expected to have a serious and complex impact on the mental health of patients with an eating disorder (ED) and of patients with obesity. The present manuscript has the following aims: (1) to analyse the psychometric properties of the COVID Isolation Eating Scale (CIES), (2) to explore changes that occurred due to confinement in eating symptomatology; and (3) to explore the general acceptation of the use of telemedicine during confinement. The sample comprised 121 participants (87 ED patients and 34 patients with obesity) recruited from six different centres. Confirmatory Factor Analyses (CFA) tested the rational-theoretical structure of the CIES. Adequate goodness-of-fit was obtained for the confirmatory factor analysis, and Cronbach alpha values ranged from good to excellent. Regarding the effects of confinement, positive and negative impacts of the confinement depends of the eating disorder subtype. Patients with anorexia nervosa (AN) and with obesity endorsed a positive response to treatment during confinement, no significant changes were found in bulimia nervosa (BN) patients, whereas Other Specified Feeding or Eating Disorder (OSFED) patients endorsed an increase in eating symptomatology and in psychopathology. Furthermore, AN patients expressed the greatest dissatisfaction and accommodation difficulty with remote therapy when compared with the previously provided face-to-face therapy. The present study provides empirical evidence on the psychometric robustness of the CIES tool and shows that a negative confinement impact was associated with ED subtype, whereas OSFED patients showed the highest impairment in eating symptomatology and in psychopathology.
|
|
| 3. |
- Humbracht, Michael, et al.
(författare)
-
Managing Hope and Spiritual Distress : The Centrality of the Doctor-Patient Relationship in Combatting Stem Cell Travel
- 2016
-
Ingår i: Bodily exchanges, Bioethics and Border Crossing : Perspectives on Giving, Selling and Sharing Bodies - Perspectives on Giving, Selling and Sharing Bodies. - 9781138858763 - 9781315717760
-
Bokkapitel (refereegranskat)abstract
- Stem Cell travel refers to patients with a variety of diseases and debilitating disorders who travel abroad to receive unproven stem cell treatments. Current academic research investigating how to combat stem cell travel has yet to offer a complete understanding of the link between patient hope and autonomy, and building or losing trust in medical authorities. To combat stem cell travel, understanding how to manage patients’ potential for hope or spiritual distress is crucial (Hyun, 2013). This article argues that re-conceptualizing the doctor-patient relationship is important to further grasp how to manage patient hope and spiritual distress. This article promotes a notion of the doctor-patient relationship that moves beyond physician paternalism and patient consumerism; instead the doctor-patient relationship should be viewed as an encounter where patient autonomy is encouraged and guided by physicians through the joint co-creation of treatment. We conclude that sharing is both fuel for stem cell travel and a means to combat it: the first through patients’ bodily sharing of their cells with stem cell purveyors for the latter’s profit and patients’ sharing information and experiences online; the second through doctors and patients sharing the construction of treatment. This manner of framing the issue offers a more realistic and ethical lens through which to view the doctor-patient relationship and combat stem travel than has been previously asserted. In making this argument, the article combines both a bioethical and ethnological approach.
|
|
| 4. |
- Thelin, Eric Peter, et al.
(författare)
-
Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics : A systematic review
- 2017
-
Ingår i: Frontiers in Neurology. - : Frontiers Media S.A.. - 1664-2295. ; 8
-
Forskningsöversikt (refereegranskat)abstract
- Background: The proteins S100B, neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and neurofilament light (NF-L) have been serially sampled in serum of patients suffering from traumatic brain injury (TBI) in order to assess injury severity and tissue fate. We review the current literature of serum level dynamics of these proteins following TBI and used the term "effective half-life" (t1/2) in order to describe the "fall" rate in serum.Materials and methods: Through searches on EMBASE, Medline, and Scopus, we looked for articles where these proteins had been serially sampled in serum in human TBI. We excluded animal studies, studies with only one presented sample and studies without neuroradiological examinations.Results: Following screening (10,389 papers), n = 122 papers were included. The proteins S100B (n = 66) and NSE (n = 27) were the two most frequent biomarkers that were serially sampled. For S100B in severe TBI, a majority of studies indicate a t1/2 of about 24 h, even if very early sampling in these patients reveals rapid decreases (1-2 h) though possibly of non-cerebral origin. In contrast, the t1/2 for NSE is comparably longer, ranging from 48 to 72 h in severe TBI cases. The protein GFAP (n = 18) appears to have t1/2 of about 24-48 h in severe TBI. The protein UCH-L1 (n = 9) presents a t1/2 around 7 h in mild TBI and about 10 h in severe. Frequent sampling of these proteins revealed different trajectories with persisting high serum levels, or secondary peaks, in patients with unfavorable outcome or in patients developing secondary detrimental events. Finally, NF-L (n = 2) only increased in the few studies available, suggesting a serum availability of >10 days. To date, automated assays are available for S100B and NSE making them faster and more practical to use.Conclusion: Serial sampling of brain-specific proteins in serum reveals different temporal trajectories that should be acknowledged. Proteins with shorter serum availability, like S100B, may be superior to proteins such as NF-L in detection of secondary harmful events when monitoring patients with TBI.
|
|
